Elmquist Eye Group now offering Durysta implant procedure for patients with glaucoma

2020-06-18T15:36:40-04:00June 18th, 2020|Categories: Health and Wellness, Media Relations, News, Public Relations|Tags: , , , , |

Elmquist Eye Group is offering a new procedure using the FDA-approved sustained-release implant, Durysta, to help administer treatment for patients with open-angle glaucoma or ocular hypertension. Glaucoma is a disease of the optic nerve – commonly associated with high eye pressures – that can lead to vision loss or blindness. Durysta delivers glaucoma treatment via [...]